Skip to content
Clinical Trials – home
GreeceBack to Greece

Clinical trials in Patras

254 clinical trials in Patras, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Patras at a glance
254
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

254 trials in Patras

Open in trial search
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Registered drug
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Topotecan Hydrochloride
  • Sponsor:Zai Lab (US) LLC
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Sponsor:Pfizer Inc.
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:[4-(6-Aminopyridazin-3-Yl)Piperidin-1-Yl][5-(4-Fluorophenoxy)-4-Methoxypyridin-2-Yl]Methanone
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:SPY002
  • Sponsor:Spyre Therapeutics Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GreeceGreece
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bi 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Other cities in Greece

The busiest research cities in the country

All 50 cities in Greece

Clinical research in Patras

What the registry says about research in the country

01 Autoimmune Conditions

Innovative research focusing on Sjögren's Syndrome and Systemic Sclerosis, evaluating novel therapeutic approaches with medications like sibeprenlimab and efgartigimod. These trials aim to improve treatment outcomes for patients with chronic autoimmune disorders.

  • Sjögren's Disease Management
  • Systemic Sclerosis Treatment
  • Inflammatory Disease Therapy

Studies are exploring both long-term safety and immediate efficacy of new treatment options.

02 Oncology Research

Comprehensive studies in Multiple Myeloma and advanced cancers, including trials of combination therapies and novel treatments. Research includes investigations into treatments for newly diagnosed and relapsed/refractory cases.

  • Multiple Myeloma Therapies
  • Lung Cancer Treatment
  • Prostate Cancer Management

Focus on improving patient outcomes through targeted and combination therapies.

03 Neurological Disorders

Groundbreaking research in Amyotrophic Lateral Sclerosis and Myasthenia Gravis, evaluating innovative treatments and therapeutic approaches for these challenging neurological conditions.

  • ALS Treatment Development
  • Neurological Disease Management
  • Chronic Neurological Conditions

Studies are examining both disease progression and symptom management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).